AU2019247217A1 - Metallo-liothyronine - Google Patents

Metallo-liothyronine Download PDF

Info

Publication number
AU2019247217A1
AU2019247217A1 AU2019247217A AU2019247217A AU2019247217A1 AU 2019247217 A1 AU2019247217 A1 AU 2019247217A1 AU 2019247217 A AU2019247217 A AU 2019247217A AU 2019247217 A AU2019247217 A AU 2019247217A AU 2019247217 A1 AU2019247217 A1 AU 2019247217A1
Authority
AU
Australia
Prior art keywords
complex
metal
biologically active
active moiety
another embodiment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019247217A
Other languages
English (en)
Inventor
Michaela E. Mulhare
Thomas Piccariello
John D. Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthonics Inc
Original Assignee
Synthonics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthonics Inc filed Critical Synthonics Inc
Publication of AU2019247217A1 publication Critical patent/AU2019247217A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AU2019247217A 2018-04-04 2019-04-04 Metallo-liothyronine Abandoned AU2019247217A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652705P 2018-04-04 2018-04-04
US62/652,705 2018-04-04
PCT/US2019/025725 WO2019195513A1 (en) 2018-04-04 2019-04-04 Metallo-liothyronine

Publications (1)

Publication Number Publication Date
AU2019247217A1 true AU2019247217A1 (en) 2020-11-26

Family

ID=68101148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019247217A Abandoned AU2019247217A1 (en) 2018-04-04 2019-04-04 Metallo-liothyronine

Country Status (9)

Country Link
US (2) US11712426B2 (https=)
EP (1) EP3773733B1 (https=)
JP (1) JP7535993B2 (https=)
KR (1) KR20200143701A (https=)
CN (1) CN112218661A (https=)
AU (1) AU2019247217A1 (https=)
BR (1) BR112020020403A8 (https=)
CA (1) CA3096199A1 (https=)
WO (1) WO2019195513A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11712426B2 (en) * 2018-04-04 2023-08-01 Synthonics, Inc. Metallo-liothyronine
JP2022030705A (ja) * 2020-08-07 2022-02-18 日本曹達株式会社 チアベンダゾール含有配位高分子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298613B1 (it) * 1998-03-10 2000-01-12 Bracco Spa Chelati complessi di manganese ad alta relassivita' in siero
JP2003261683A (ja) * 2002-03-06 2003-09-19 Nof Corp 中性（ベンゼン−１，２，４，５−テトラチオラート）金属錯体ポリマー、その製造方法および用途
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
AU2013205471B2 (en) 2005-10-24 2016-02-11 Synthonics, Inc. Metal coordinated compositions
JP5162758B2 (ja) * 2006-03-02 2013-03-13 大学共同利用機関法人自然科学研究機構 マイクロチャンネルリアクター
EP2536408A1 (en) * 2010-02-16 2012-12-26 Wockhardt Research Centre Efflux pump inhibitors
US10150792B2 (en) * 2010-11-08 2018-12-11 Synthonics, Inc. Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients
JP6183763B2 (ja) * 2014-05-02 2017-08-23 国立研究開発法人物質・材料研究機構 有機／ヘテロ金属ハイブリットポリマー、その合成方法、有機／ヘテロ金属ハイブリットポリマーの膜、有機／マルチ金属ハイブリットポリマー、その合成方法、及び有機／マルチ金属ハイブリットポリマーの膜
CA2951923A1 (en) * 2014-06-18 2015-12-23 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of active agents
JP6838268B2 (ja) * 2015-10-21 2021-03-03 コニカミノルタ株式会社 光変換材料、光変換フィルム、及び発光素子
US11712426B2 (en) * 2018-04-04 2023-08-01 Synthonics, Inc. Metallo-liothyronine

Also Published As

Publication number Publication date
JP7535993B2 (ja) 2024-08-19
EP3773733A4 (en) 2022-05-25
US20230381126A1 (en) 2023-11-30
EP3773733A1 (en) 2021-02-17
US11712426B2 (en) 2023-08-01
CA3096199A1 (en) 2019-10-10
EP3773733C0 (en) 2025-11-12
BR112020020403A8 (pt) 2021-04-13
EP3773733B1 (en) 2025-11-12
KR20200143701A (ko) 2020-12-24
BR112020020403A2 (pt) 2021-03-23
JP2021521268A (ja) 2021-08-26
CN112218661A (zh) 2021-01-12
US20210046032A1 (en) 2021-02-18
WO2019195513A1 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
EP3295935B1 (en) Crystallization method and bioavailability
US20230381126A1 (en) Metallo-liothyronine
DK2531200T3 (en) COSTALLIZATION PROCEDURE AND BIOTA ACCESSIBILITY
TWI568453B (zh) 具有螯合型複合微胞之藥物載體及其應用
US6180094B1 (en) Remedies for hyperphosphatemia
JPH10509143A (ja) ２，２′−ジチオ−ビス（エタンスルホネート）（ジメスナ）と組み合わせたシスプラチン組成物
US20110275792A1 (en) Metal coordinated compositions
CA2997378A1 (en) Crystallization method and bioavailability
JPS5879022A (ja) 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
WO2014071757A1 (zh) 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN106581683A (zh) 一种聚乙二醇修饰的金属有机纳米材料及其制备方法、应用
SG193495A1 (en) Gallium complexes, pharmaceutical compositions and methods of use
CN110787303B (zh) 一种Pt与巯基化合物的加合物Pt-SR、制备及应用
US20170224728A1 (en) Iron-based montmorillonite medicament for treating hyperphosphatemia and iron-deficiency anemia, and preparation method therefor
HK1171966B (en) Crystallization method and bioavailability
HK1171966A (en) Crystallization method and bioavailability

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted